Showing 1 - 7 results of 7 for search 'Zi-Xun Yan', query time: 0.04s Refine Results
  1. 1
    Transgenic expression of IL-7 regulates CAR-T cell metabolism and enhances in vivo persistence against tumor cells

    Transgenic expression of IL-7 regulates CAR-T cell metabolism and enhances in vivo persistence against tumor cells by Li Li, Qing Li, Zi-Xun Yan, Ling-Shuang Sheng, Di Fu, Pengpeng Xu, Li Wang, Wei-Li Zhao

    Published 2022-07-01
    Get full text
    Article
  2. 2
    CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis

    CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis by Chen-xing Zhao, Zi-xun Yan, Jing-jing Wen, Di Fu, Peng-peng Xu, Li Wang, Shu Cheng, Jian-da Hu, Wei-li Zhao

    Published 2021-12-01
    Get full text
    Article
  3. 3
    Cholesterol efflux from C1QB-expressing macrophages is associated with resistance to chimeric antigen receptor T cell therapy in primary refractory diffuse large B cell lymphoma

    Cholesterol efflux from C1QB-expressing macrophages is associated with resistance to chimeric antigen receptor T cell therapy in primary refractory diffuse large B cell lymphoma by Zi-Xun Yan, Yan Dong, Niu Qiao, Yi-Lun Zhang, Wen Wu, Yue Zhu, Li Wang, Shu Cheng, Peng-Peng Xu, Zi-Song Zhou, Ling-Shuang Sheng, Wei-Li Zhao

    Published 2024-06-01
    Get full text
    Article
  4. 4
    A novel lncRNA TCLlnc1 promotes peripheral T cell lymphoma progression through acting as a modular scaffold of HNRNPD and YBX1 complexes

    A novel lncRNA TCLlnc1 promotes peripheral T cell lymphoma progression through acting as a modular scaffold of HNRNPD and YBX1 complexes by Ping Zhao, Meng-Meng Ji, Ying Fang, Xiao Li, Hong-Mei Yi, Zi-Xun Yan, Shu Cheng, Peng-Peng Xu, Anne Janin, Chao-Fu Wang, Li Wang, Wei-Li Zhao

    Published 2021-03-01
    Get full text
    Article
  5. 5
    JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide

    JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide by Peng-Peng Xu, Yi-Feng Sun, Ying Fang, Qi Song, Zi-Xun Yan, Yi Chen, Xu-Feng Jiang, Xiao-Chun Fei, Yan Zhao, Christophe Leboeuf, Biao Li, Chao-Fu Wang, Anne Janin, Li Wang, Wei-Li Zhao

    Published 2017-08-01
    Get full text
    Article
  6. 6
    18F-FDG PET/CT metrics-based stratification of large B-cell lymphoma receiving CAR-T cell therapy: immunosuppressive tumor microenvironment as a negative prognostic indicator in patients with high tumor burden

    18F-FDG PET/CT metrics-based stratification of large B-cell lymphoma receiving CAR-T cell therapy: immunosuppressive tumor microenvironment as a negative prognostic indicator in pa... by Ling-Shuang Sheng, Rong Shen, Zi-Xun Yan, Chao Wang, Xin Zheng, Yi-Lun Zhang, Hao-Xu Yang, Wen Wu, Peng-Peng Xu, Shu Cheng, Emmanuel Bachy, Pierre Sesques, Nicolas Jacquet-Francillon, Xu-Feng Jiang, Wei-Li Zhao, Li Wang

    Published 2024-09-01
    Get full text
    Article
  7. 7
    Clinical efficacy and tumour microenvironment influence of decitabine plus R‐CHOP in patients with newly diagnosed diffuse large B‐Cell lymphoma: Phase 1/2 and biomarker study

    Clinical efficacy and tumour microenvironment influence of decitabine plus R‐CHOP in patients with newly diagnosed diffuse large B‐Cell lymphoma: Phase 1/2 and biomarker study by Mu‐Chen Zhang, Ying Fang, Peng‐Peng Xu, Lei Dong, Rong Shen, Yao‐Hui Huang, Di Fu, Zi‐Xun Yan, Shu Cheng, Xu‐Feng Jiang, Qi Song, Yang He, Yan Zhao, Min Lu, Jing Ye, Feng Liu, Lin Cheng, Chao‐Fu Wang, Li Wang, Wei‐Li Zhao

    Published 2021-12-01
    Get full text
    Article

Search Tools: